Quick answers
- What is Mozobil?
- Mozobil is a brand name of Plerixafor, a prescription medicine. The FDA NDC Directory lists 1 Mozobil product in 1 strength and form.
- Who makes Mozobil?
- Genzyme holds the FDA application for Mozobil (NDA022311, approved December 15, 2008).
- Is there a generic or store brand of Mozobil?
- Yes. The FDA NDC Directory lists 6 other products with the same active ingredients, strength and form as a Mozobil product, 6 of them generic. Ask your pharmacist whether one is right for you.
- Has Mozobil been recalled?
- FDA enforcement reports list 2 recalls of Mozobil products; the newest started September 1, 2016. A recall usually concerns specific lots, not every product.
What Mozobil is
Each Mozobil product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Plerixafor · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| plerixafor 24 mg/1.2 mL injection, solution (subcutaneous) | Mozobil | 6 products, 6 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Plerixafor →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA022311 | Genzyme | December 15, 2008 | 1 |
Companies that list Mozobil
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Mozobil products.
- Sanofi-Aventis U.S. LLC1 product
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
September 1, 2016 · Class III · Terminated · D-0704-2017
Labeling: Incorrect or Missing Package Insert
Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx Only, Manufactured by: Genzyme Corporation 500 Kendall Street, Cambridge, MA 02412 USA NDC: 0024-5862-01 — Sanofi-Aventis U.S. LLC
-
August 4, 2016 · Class III · Terminated · D-1518-2016
Labeling: Incorrect or Missing Lot and/or Exp. Date
Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 A Sanofi Company Country of Origin — Genzyme Corporation / Genzyme Biosurgery
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.